James Millis
Keine laufenden Positionen mehr
Profil
James Millis served as the Chief Executive Officer of Draths Corp.
from 2007 to 2009.
He then worked as a Principal at Cargill, Inc., Maxygen, Inc., Novozymes A, and Bio-Technical Resources.
From 2009 to 2018, he served as the Chief Technology Officer of BioAmber, Inc. Millis holds a graduate degree from the University of Pittsburgh and an undergraduate degree from Cornell University.
Ehemalige bekannte Positionen von James Millis
| Unternehmen | Position | Ende |
|---|---|---|
| BIOAMBER INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.09.2018 |
Draths Corp.
 Draths Corp. Pharmaceuticals: MajorHealth Technology Draths Corp. manufactured bio-chemical products. The company was founded by John W. Frost, Mark Stowers and Karen M. Draths in 2005 and was headquartered in Emeryville, CA. | Präsident | 01.01.2009 |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Bio-Technical Resources
 Bio-Technical Resources Miscellaneous Commercial ServicesCommercial Services Part of Arkion Life Sciences LLC, Bio-Technical Resources engages in research and development of new strains and process technologies. The company is based in Manitowoc, WI. Founded in 1962. | Corporate Officer/Principal | - |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
Ausbildung von James Millis
| Cornell University | Undergraduate Degree |
| University of Pittsburgh | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Draths Corp.
Draths Corp. Pharmaceuticals: MajorHealth Technology Draths Corp. manufactured bio-chemical products. The company was founded by John W. Frost, Mark Stowers and Karen M. Draths in 2005 and was headquartered in Emeryville, CA. | Health Technology |
Cargill, Inc.
 Cargill, Inc. Agricultural Commodities/MillingProcess Industries Cargill, Inc. engages in the provision of food, agricultural, financial, and industrial products and services. It specializes in food service, agriculture, meat and poultry, transportation, pharmaceutical ingredients, and beauty products. The company was founded by William Wallace Cargill in 1865 and is headquartered in Minneapolis, MN. | Process Industries |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Bio-Technical Resources
Bio-Technical Resources Miscellaneous Commercial ServicesCommercial Services Part of Arkion Life Sciences LLC, Bio-Technical Resources engages in research and development of new strains and process technologies. The company is based in Manitowoc, WI. Founded in 1962. | Commercial Services |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
BioAmber, Inc.
 BioAmber, Inc. Chemicals: SpecialtyProcess Industries BioAmber, Inc. is an industrial biotechnology company, which produces sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in everyday products, including plastics, resins, paints, food additives and personal care products. The firm's products include bio-based succinic acid, butanediol and bio-based disodium succinate. The company was founded on October 15, 2008 and is headquartered in Montreal, Canada. | Process Industries |
